Prevention of atopic dermatitis

F1000 Medicine Reports

Volumn 4, Issue 1, 2012, Pages

  Williams, Hywel C ^a,b   Chalmers, Joanne R ^a   Simpson, Eric L ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNITY; BUD; DIETARY INTAKE; IMMUNE RESPONSE; SENSITIZATION;

EID: 84873102418     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M4-24     Document Type: Article

References (42)

1. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832-6. (Pubitemid 38608590)
2. Williams HC: Atopic Dermatitis. N Eng J Med 2005, 352:2314-24.
3. van der Hulst AE, Klip H, Brand PL: Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007, 120:565-69. (Pubitemid 47334839)
4. Marenholz I, Bauerfeind A, Esparza-Gordillo J, Kerscher T, Granell R, Nickel R, Lau S, Henderson J, Lee YA: The eczema risk variant on chromosome 11q13 (rs7927894) in the population-based ALSPAC cohort: a novel susceptibility factor for asthma and hay fever. Hum Mol Genet 2011, 20:2443-9.
5. Spergel JM: From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010, 105:99-106.
6. Odhiambo J, Williams H, Clayton T, Robertson C, Asher MI; the ISAAC Phase Three Study group: Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009, 124:1251-8.
7. Shaw TE, Currie GP, KoudelkaCW, Simpson EL: Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011, 131:67-73.
8. Williams H, Stewart A, von Mutius E, Cookson B, Anderson HR; the International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study groups: Is eczema really on the increase worldwide? Journal Allergy and Clinical Immunology 2008, 121:947-54.
9. Cookson WO, Moffatt MF: The genetics of atopic dermatitis. Curr Opin Allergy Clin Immunol 2002, 2:383-7. (Pubitemid 35239518)
10. Brown SJ, McLean WH: One remarkable molecule: filaggrin. J Invest Dermatol 2012, 132:751-62.
11. Williams HC: Atopic eczema - why we should look to the environment. Br Med J 1995, 311:1241-2.
12. Strachan DP: Hay fever, hygiene, and household size. Br Med J 1989, 299:1259-60. (Pubitemid 19280051)
13. Flohr C, Yeo L: Atopic dermatitis and the hygiene hypothesis revisited. Curr Probl Dermatol 2011, 41:1-34.
14. Flohr C, Johansson SGO, Wahlgren CF, Williams HC: How "atopic" is atopic dermatitis? J Allergy Clin Immunol 2004, 114:150-8.
15. Flohr C, Weiland SK, Weinmayr G, Björkstén B, Bråbäck L, Brunekreef B, Büchele G, Clausen M, Cookson WOC, von Mutius E, Strachan DP, Willams HC; the ISAAC Phase Two Study Group: The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. J Allergy Clin Immunol 2008, 121:141-7.
16. Hoare C, Li Wan Po A, Williams HC: Systematic review of treatments for atopic eczema. Health Technol Assess 2000, 4(37):1-191.
17. Foisy M, Boyle RJ, Chalmers JR, Simpson EL, Williams HC: The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Ev-Based Child Health 2011, 6:322-39.
18. Rautava S, Kainonen E, Salminen S, Isolauri E: Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012.
19. Harris JM, Williams HC, White C, Moffat S, Mills P, Newman Taylor AJ, Cullinan P: Early allergen exposure and atopic eczema. Br J Dermatol 2007, 156:698-704. (Pubitemid 46452343)
20. Halabi-Tawil M, Ruemmele FM, Fraitag S, Rieux-Laucat F, Neven B, Brousse N, Prost Y de, Fischer A, Goulet O, Bodemer C: Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009, 160:645-51.
21. Du Toit G, Katz Y, Sasieni P, Mesher D, Maleki SJ, Fisher HR, Fox AT, Turcanu V, Amir T, Zadik-Mnuhin G, Cohen A, Livne I, Lack G: Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008, 122:984-91.
22. Learning About Peanut Allergy - the LEAP study. [http://www.leapstudy.co. uk/]
23. Mpairwe H, Webb EL, Muhangi L, Ndibazza J, Akishule D, Nampijja M, Ngom-wegi S, Tumusime J, Jones FM, Fitzsimmons C, Dunne DW, Muwanga M, Rodrigues LC, Elliott AM: Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol 2011, 22:305-12.
24. Flohr C, Tuyen LN, Quinnell RJ, Lewis S, Minh TT, Campbell J, Simmons C, Telford G, Brown A, Hien TT, Farrar J, Williams H, Pritchard DI, Britton J: Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam. Clin Exp Allergy 2010, 40:131-42.
25. Erb KJ: Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases? Trends Immunol 2009, 30:75-82.
26. Linde YW: Dry skin in atopic dermatitis. Acta Derm Venereol 1992, 177(Suppl Stockh):9-13.
27. Baurecht H, Irvine AD, Novak N, Illig T, Bühler B, Ring J,Wagenpfeil S, Weidinger S: Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007, 120:1406-12. (Pubitemid 350216605)
28. Rodríguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ, Irvine AD, Weidinger S: Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009, 123:1361-70.
29. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R: New perspectives on epidermal barrier dysfunction in atopic dermatitis: geneenvironment interactions. J Allergy Clin Immunol 2006, 118:3-21. (Pubitemid 43946484)
30. Tang TS, Bieber T, Williams HC: Does "autoreactivity" play a role in atopic dermatitis? J Allergy Clin Immunol 2012, 129:1209-15.
31. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ: Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009, 129:1892-908.
32. Centre of Evidence-Based Dermatology Barrier Enhancement Eczema Prevention (BEEP) Pilot Study. [http://www. beepstudy.org/]
33. Elias PM, Wakefield JS: Therapeutic implications of a barrierbased pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 2011, 41:282-95.
34. Kim BE, Leung DY: Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res 2012, 4:12-16.
35. Miller DW, Koch SB, Yentzer BA, Clark AR, O'Neill JR, Fountain J, Weber TM, Fleischer AB Jr.: An over-the-countermoisturizer is as clinically effective as, andmore cost-effective than, prescription barrier creams in the treatment of children with mild-tomoderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol 2011, 10:531-7.
36. Bieber T, Cork M, Reitamo S: Atopic dermatitis: a candidate for disease-modifying strategy. Allergy 2012 Jun 4. doi: 10.1111/j.1398- 9995.2012.02845.x. [Epub ahead of print] .
37. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C: Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 2011, 164:415-28.
38. Williams HC: Preventing eczema flares with topical corticosteroids or tacrolimus: which is best? Br J Dermatol 2011, 164:231-3.
39. Uehara M, Miyauchi H: The morphologic characteristics of dry skin in atopic dermatitis. Arch Dermatol 1984, 120:1186-90. (Pubitemid 14026209)
40. Simpson E, Chalmers J, Keck L, Williams HC: How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies. J Allergy Clin Immunol 2012, 130:137-44.
41. Danby SG, Al-Enezi T, Sultan A, Chittock J, Kennedy K, Cork MJ: The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis. Br J Dermatol 2011, 165:329-34.
42. Williams HC: Inflammatory SkinDiseases I: AtopicDermatitis. In The Challenge of Dermato-Epidemiology. Edited by Williams HC, Strachan DP. Boca Raton; CRC Press Inc.; 1997:125-44.